top of page

ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL

Product details

Registration number: SIN15397P

Classification: Prescription Only

Active ingredients: Irinotecan (anhydrous free base)

Strength: 4.33 mg/mL

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Registrant: SERVIER (S) PTE LTD

ATC code: L01CE02

HSA approval date: 28 December 2017

Manufacturer(s):

  • Ipsen Biosciences, Inc.
  • Ajinomoto Althea, Inc.
  • IPSEN PHARMA BIOTECH

Manufacturing country/countries: UNITED STATES; FRANCE

What are the HSA registration number and classification for ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15397P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Irinotecan (anhydrous free base)

Strength: 4.33 mg/mL

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL?

According to the HSA dataset updated 7 August 2026:

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL?

According to the HSA dataset updated 7 August 2026:

Registrant: SERVIER (S) PTE LTD

Source for this answer

Which manufacturers and countries are listed for ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Ipsen Biosciences, Inc.
  • Ajinomoto Althea, Inc.
  • IPSEN PHARMA BIOTECH

Manufacturing country/countries: UNITED STATES; FRANCE

Source for this answer

Where can I look up ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15397P or the exact product name ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15397P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page